Klinger Alexandra L, McComsey David F, Smith-Swintosky Virginia, Shank Richard P, Maryanoff Bruce E
Research & Early Development, Johnson & Johnson Pharmaceutical Research & Development, Spring House, Pennsylvania 19477-0776, USA.
J Med Chem. 2006 Jun 15;49(12):3496-500. doi: 10.1021/jm058279n.
This paper examines the relative effectiveness of bioisosteric sulfamate and sulfamide derivatives for inhibition of human carbonic anhydrase-II (CA-II) by using a direct binding assay based on the ThermoFluor method (Matulis et al. Biochemistry 2005, 44, 5258). Compounds 1-10, which represent five cognate sulfamate/sulfamide pairs, were studied by ThermoFluor to obtain binding affinities (K(a) values). The corresponding dissociation constants, K(d), provide an independent measure of CA-II activity relative to commonly used K(i) values from enzyme kinetics studies. There was a sizable difference in potency between the sulfamates and sulfamides, with the sulfamides being much less potent, by factors ranging from 25 (7/8) to 1,200 (3/4). These results are consistent with our recent report that sulfamides tend to be much weaker inhibitors of CA-II than their corresponding sulfamates (Maryanoff et al. J. Med. Chem. 2005, 48, 1941). Additionally, for arylsulfamides 10-12 the K(d) values determined by ThermoFluor and the K(i) values determined from enzyme kinetics are consistent. It appears that the sulfamide group is less suitable than the sulfamate group for obtaining potent inhibition of CA-II.
本文采用基于热荧光法的直接结合试验(Matulis等人,《生物化学》,2005年,第44卷,第5258页),研究了生物电子等排体氨基磺酸酯和氨基磺酰胺衍生物对人碳酸酐酶-II(CA-II)的抑制效果。通过热荧光法研究了代表五对同源氨基磺酸酯/氨基磺酰胺的化合物1-10,以获得结合亲和力(K(a)值)。相应的解离常数K(d)提供了一种相对于酶动力学研究中常用的K(i)值来独立衡量CA-II活性的方法。氨基磺酸酯和氨基磺酰胺之间的效力存在相当大的差异,氨基磺酰胺的效力要弱得多,相差倍数从25(7/8)到1200(3/4)不等。这些结果与我们最近的报告一致,即氨基磺酰胺作为CA-II的抑制剂往往比其相应的氨基磺酸酯弱得多(Maryanoff等人,《药物化学杂志》,2005年,第48卷,第1941页)。此外,对于芳基氨基磺酰胺10-12,通过热荧光法测定的K(d)值和从酶动力学测定的K(i)值是一致的。看来氨基磺酰胺基团比氨基磺酸酯基团更不适于获得对CA-II的有效抑制。